Anara Impact Capital Leads $1.45 Million Round for Egyptian Healthtech Reme-D

Egyptian healthtech company Reme-D has secured $1.45 million in a pre-Series A funding round led by Anara Impact Capital. The round also attracted investment from the Global Innovation Fund, Africa Health Ventures and other backers. Reme-D plans to use the capital to expand its manufacturing operations, enter additional African markets and broaden its portfolio of molecular diagnostic products.